As society faces the challenges of COVID-19, research from Osaka Metropolitan University on COVID-19-associated pulmonary aspergillosis (CAPA) is significant. This severe lung infection has been reported to occur in 3.8% to 35% of cases globally. Analyzing over 150,000 COVID-19 cases from 2020 to 2021, the study found CAPA in 0.4% to 2.7% of 33,000 severely ill patients.
Research focuses on COVID-19-related illnesses in Japan
Aspergillosis of the lungs due to COVID-19
- Advertisement -
Explore more ..
High-fat diets and memory loss- A reversible story
Machine learning identifies early depression signals in facial patterns.
Why alcohol halts liver regeneration, even after quitting
New research links inflammation to faulty RNA processing
Breakthrough stool test could replace invasive colonoscopies
An artificial intelligence-based approach to diagnose colorectal cancer from the gut microbiota.
TRENDING
- Advertisement -